# Esperion Therapeutics Inc. (ESPR) — Revenue

## Annual Revenue (USD)

| Year | Revenue |
| --- | --- |
| 2025 | $403M |
| 2024 | $332M |
| 2023 | $116M |
| 2022 | $75M |
| 2021 | $78M |
| 2020 | $228M |
| 2019 | $148M |
| 2018 | — |

## Quarterly Revenue (USD)

| Quarter | Revenue |
| --- | --- |
| 2026-03-31 | $80M |
| 2025-09-30 | $87M |
| 2025-06-30 | $82M |
| 2025-03-31 | $65M |
| 2024-09-30 | $52M |
| 2024-06-30 | $74M |
| 2024-03-31 | $138M |
| 2023-09-30 | $34M |
| 2023-06-30 | $26M |
| 2023-03-31 | $24M |
| 2022-09-30 | $19M |
| 2022-06-30 | $19M |
| 2022-03-31 | $19M |
| 2021-09-30 | $14M |
| 2021-06-30 | $41M |
| 2021-03-31 | $8M |
| 2020-09-30 | $4M |
| 2020-06-30 | $212M |
| 2020-03-31 | $2M |
| 2019-09-30 | $981,000 |
| 2019-06-30 | $982,000 |
| 2019-03-31 | $145M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/ESPR/revenue)